|4Mar 19, 9:03 PM ET

Daruwala Paul 4

4 · Cidara Therapeutics, Inc. · Filed Mar 19, 2021

Insider Transaction Report

Form 4
Period: 2021-03-17
Daruwala Paul
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-03-17+120,000120,000 total
    Exercise: $2.55Exp: 2031-03-16Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021.

Documents

1 file
  • 4
    wf-form4_161620220696295.xmlPrimary

    FORM 4